Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide
Author Archive for: m16Dev
This author has yet to write their bio.Meanwhile lets just say that we are proud m16Dev contributed a whooping 10 entries.
Entries by m16Dev
Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide GENOSYL® DS facilitates homebound use of inhaled nitric oxide in the treatment of pulmonary hypertension in patients with COVID-19 infection March 24, 2020, – VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the […]
Prestigious investor conference runs concurrently with 38th Annual J.P. Morgan Healthcare Conference Atlanta, January 10, 2020, – VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering and improving the healthcare economics, is pleased to announce it will be presenting at Biotech Showcase 2020. Biotech Showcase 2020 will take place concurrently with the […]
The GENOSYL® inhaled nitric oxide approval represents the first and only FDA-approved tankless delivery system and is an important new development in the clinical application of inhaled nitric oxide. FOR IMMEDIATE RELASE Contact: Ray Russo (908) 313-7172 Ray.Russo@VERO-biotech.com December 20, 2019, – VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering […]
We will be attending the 2018 AARC Congress in Las Vegas on December 4-7 2018. Come and visit our booth to learn about the great things happening at VERO Biotech!
For Immediate Release Contact: Ray Russo (908) 313 -7172 Ray.Russo@VERO-biotech.com Atlanta-based biotech company expands with addition of renowned Duke University School of Medicine and Health System respiratory and critical care expert. October 5, 2018, Atlanta, GA – VERO Biotech LLC, a biopharmaceutical company focused on the design, development and commercialization of next generation inhaled nitric […]
ATLANTA —VERO Biotech has opened a new 15,585-square-foot headquarters at the Georgia Institute of Technology’s Technology Enterprise Park in Atlanta. The biopharmaceutical company, formerly known as GeNO LLC, designs, develops and commercializes products for patients with pulmonary and cardiac diseases. VERO Biotech will move its administrative, research & development and manufacturing departments from its current […]
The biotechnology company left Florida for the Peach State, setting up shop in a 15,600-square-foot space at Georgia Tech’s Technology Enterprise Park. Atlanta has reeled in another headquarters tenant. VERO Biotech recently wrapped up the relocation of its home base from Cocoa, Fla., to Georgia Tech’s Technology Enterprise Park (TEP) in Midtown Atlanta. VERO Biotech has […]